Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: immune checkpoint inhibitors (Click to remove) In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic Neurologist 27:290-297, Gritsch, D.,et al, 2022 Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors Neurol 96:e866-e875, Vogrig, A.,et al, 2021 Encephalitis Induced by Immune Checkpoint Inhibitors JAMA Neurol 78:864-873, Velasco, R.,et al, 2021 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Sensory Ganglionopathy NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Showing articles 0 to 10 of 10